Epidemiology of Moyamoya disease in China: A nationwide hospital-based study

The national epidemiologic data in mainland China is still absent for moyamoya disease (MMD). This study was a nationwide hospital-based observational retrospective study to estimate epidemiological characteristics of MMD. The data was based on the Hospital Quality Monitoring System (HQMS), a nation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet regional health. Western Pacific 2022-01, Vol.18, p.100331-100331, Article 100331
Hauptverfasser: Zhang, Dong, Huang, Liangran, Huang, Zheng, Zhou, Qi, Yang, Xin, Gu, Hongqiu, Li, Zixiao, Shi, Ying, Gan, Lanxia, Wang, Haibo, Ma, Xvdong, Wang, Yongjun, Zhao, Jizong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The national epidemiologic data in mainland China is still absent for moyamoya disease (MMD). This study was a nationwide hospital-based observational retrospective study to estimate epidemiological characteristics of MMD. The data was based on the Hospital Quality Monitoring System (HQMS), a national database which covers all tertiary hospitals in mainland China. This system consistently collects medical records including demographic characteristics, diagnoses, procedures, and expenses etc. for all inpatients. MMD was identified by ICD-10 code (I67·5) in HQMS. A total of 47,443 new-onset patients with total 69,680 hospitalization records from 1312 hospitals during 2016 to 2018 were included. The annual incidence rate was 1·14 per 100,000 inhabitants (95% CI, 1·12–1·16) and approximately a 2-fold increase from 2016 to 2018. The incidence in children (0·18 per 100,000 inhabitants per year; 95% CI, 0·17–0·20) was significantly lower than that in adults (1·40 per 100,000; 95% CI, 1·38–1·42) (P
ISSN:2666-6065
2666-6065
DOI:10.1016/j.lanwpc.2021.100331